ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Sequestration Hurts Kids with Cancer

March 15, 2013

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000